$0.935700
-0.01-1.14%
At Close: -
$0.923600
-0.01-1.29%
After Hours: Jul 5, 7:54 PM EDT
15 minutes delayed
Akebia Therapeutics
AKBANASDAQ
Akebia Therapeutics (NASDAQ:AKBA) Stock, Short Interest Report
Short interest for Akebia Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Akebia Therapeutics's stock. Short interest data is updated every two weeks.
Short Interest
12.3M
Short Interest %
5.93%
Days to Cover
6.57
| Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. Comm | 06/26/2024 | 5.93% | 207,349,151 | 12,296,514 | 1,870,195 | 6.57 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 06/11/2024 | 6.34% | 207,349,151 | 13,155,199 | 2,461,652 | 5.34 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 05/24/2024 | 5.64% | 207,349,151 | 11,698,707 | 3,302,665 | 3.54 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 05/09/2024 | 5.72% | 207,349,151 | 11,864,826 | 2,690,609 | 4.41 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 04/24/2024 | 6.60% | 207,348,027 | 13,689,136 | 5,798,042 | 2.36 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 04/09/2024 | 6.47% | 207,157,771 | 13,400,139 | 13,542,889 | 1 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 03/26/2024 | 4.89% | 207,157,771 | 10,126,415 | 3,788,922 | 2.67 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 03/11/2024 | 4.22% | 192,368,035 | 8,110,931 | 2,552,839 | 3.18 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 02/27/2024 | 4.30% | 186,174,911 | 8,004,939 | 1,662,120 | 4.82 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 02/09/2024 | 4.72% | 186,174,911 | 8,778,246 | 2,262,643 | 3.88 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 01/24/2024 | 4.21% | 186,174,911 | 7,832,705 | 2,183,063 | 3.59 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 01/10/2024 | 4.23% | 186,174,911 | 7,872,876 | 1,678,085 | 4.69 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 12/27/2023 | 3.94% | 186,174,911 | 7,328,941 | 1,116,557 | 6.56 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 12/11/2023 | 4.84% | 186,174,911 | 9,010,651 | 705,507 | 12.77 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 11/27/2023 | 5.31% | 186,174,911 | 9,881,875 | 1,780,025 | 5.55 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 11/09/2023 | 5.55% | 186,099,303 | 10,320,484 | 1,514,484 | 6.81 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 10/24/2023 | 4.16% | 186,099,303 | 7,745,428 | 1,456,489 | 5.32 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 10/10/2023 | 3.91% | 186,099,303 | 7,282,740 | 1,052,626 | 6.92 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 09/26/2023 | 3.88% | 186,099,303 | 7,229,016 | 1,337,567 | 5.4 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 09/12/2023 | 3.12% | 186,099,303 | 5,809,726 | 1,556,735 | 3.73 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 08/24/2023 | 3.68% | 183,713,617 | 6,755,146 | 2,168,072 | 3.12 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 08/09/2023 | 3.34% | 183,713,617 | 6,128,216 | 2,479,577 | 2.47 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 07/25/2023 | 2.93% | 183,713,617 | 5,386,233 | 1,740,484 | 3.09 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 07/12/2023 | 2.64% | 183,713,617 | 4,842,091 | 1,749,980 | 2.77 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 06/27/2023 | 2.37% | 183,713,617 | 4,354,691 | 1,929,695 | 2.26 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 06/09/2023 | 2.80% | 183,713,617 | 5,145,484 | 2,906,386 | 1.77 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 05/24/2023 | 2.22% | 183,713,617 | 4,072,786 | 1,465,104 | 2.78 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 05/09/2023 | 2.45% | 183,713,617 | 4,498,852 | 1,339,202 | 3.36 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 04/25/2023 | 3.09% | 183,713,617 | 5,682,224 | 891,623 | 6.37 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 04/12/2023 | 3.08% | 183,621,442 | 5,661,211 | 1,057,318 | 5.35 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 03/24/2023 | 3.67% | 182,297,059 | 6,682,672 | 2,373,745 | 2.82 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 03/09/2023 | 4.59% | 182,297,059 | 8,375,367 | 2,749,441 | 3.05 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 02/27/2023 | 2.52% | 182,297,059 | 4,585,928 | 3,921,825 | 1.17 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 02/09/2023 | 1.82% | 182,294,959 | 3,324,871 | 1,387,819 | 2.4 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 01/25/2023 | 2.53% | 182,160,455 | 4,615,079 | 1,867,474 | 2.47 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 01/11/2023 | 2.56% | 182,160,455 | 4,661,920 | 2,235,709 | 2.09 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 12/27/2022 | 2.57% | 181,986,824 | 4,681,940 | 2,414,734 | 1.94 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 12/09/2022 | 2.65% | 181,986,824 | 4,821,913 | 1,340,758 | 3.6 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 11/25/2022 | 3.03% | 181,986,824 | 5,506,049 | 1,312,432 | 4.2 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 11/09/2022 | 3.25% | 181,986,824 | 5,920,665 | 1,050,803 | 5.63 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 10/25/2022 | 3.46% | 181,976,324 | 6,294,297 | 1,160,699 | 5.42 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 10/11/2022 | 3.99% | 181,976,324 | 7,263,898 | 1,412,641 | 5.14 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 09/26/2022 | 4.24% | 181,873,395 | 7,711,554 | 2,047,737 | 3.77 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 09/12/2022 | 4.39% | 181,873,395 | 7,986,128 | 2,318,407 | 3.44 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 08/24/2022 | 5.13% | 181,873,395 | 9,337,071 | 5,233,262 | 1.78 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 08/09/2022 | 6.30% | 181,873,395 | 11,463,519 | 2,929,597 | 3.91 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 07/26/2022 | 6.22% | 181,729,395 | 11,299,087 | 14,114,644 | 1 | Get Alert |
| AKBA | Akebia Therapeutics, Inc. Comm | 07/12/2022 | 5.20% | 181,729,395 | 9,456,307 | 20,675,615 | 1 | Get Alert |
Looking for the most shorted stocks?